Morningside Group supports technology companies at critical development stages.
Portfolio
4
companies
Cyted Health
Cyted Health develops gastrointestinal molecular diagnostics for early esophageal disease detection.
Evonetix
Evonetix builds semiconductor technology platforms for desktop DNA synthesis.
Ieso Digital Health
Digital mental healthcare provider developing AI enabled therapeutics.
Rockley Photonics
Rockley Photonics provides integrated silicon photonic solutions for sensor and communication products.
Mick Sawka
Investment Manager
Stephen Bruso
Morningside Ventures
The financing round was led by EQT Life Sciences alongside co-leads Advent Life Sciences and British Business Bank.
"This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier. This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio."
The oversubscribed round included backing from Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence.
"This substantial investment round demonstrates continued confidence in the progress of our technical development and its potential to revolutionise the accessibility of gene synthesis. Evonetix is in a very exciting phase, having recently opened our early access program. This investment will support us as we execute on our commercial strategy to put benchtop gene synthesis in the hands of users."
Morningside led the Series B financing to support regulatory approvals and market entry for clinical software treatments.
"At ieso, we’re looking to transform global mental health by unlocking the power of clinical data to develop AI-enabled digital therapeutics. Our experience delivering outstanding mental health care within the NHS ideally places us for starting to tackle this challenge. A new generation of clinically-validated digital mental health care products could ultimately improve millions of lives. But we cannot do this alone, and look forward to working with our patients, clinicians, investors, as well as existing and future partners, to better serve those who require mental health support."
The funding round was supported by Morningside Ventures and new private funds.
"There is tremendous need for technologies that can enable effective digital health and wellness, driven by the associated benefit provided to population health,"
